Literature DB >> 7542508

Palliative therapies in elderly cancer patients.

F Porzsolt1, J Zeeh, D Platt.   

Abstract

Palliative therapy in elderly cancer patients deserves special attention because of differences between young and elderly cancer patients. In elderly patients, the treatment produces more adverse effects and the disease is cured less frequently, but the prognosis is usually better than in young patients with cancer. In the elderly population, cancer is seen more frequently than in the young population, yet elderly patients are less frequently included in trials. It is obvious that the results obtained from the treatment of young cancer patients do not necessarily apply to elderly cancer patients. The existing lack of formal data for the management of elderly cancer patients justifies 5 distinctive steps: collection of individual information; review of the available and appropriate knowledge; definition and specification of treatment goals; selection of treatment tools; and assessment of outcome. Following these steps will lead to coordination of oncology and palliative medicine.

Entities:  

Mesh:

Year:  1995        PMID: 7542508     DOI: 10.2165/00002512-199506030-00003

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  87 in total

1.  Functional criteria for staging and treatment of hairy cell leukemia.

Authors:  F Porzsolt; J Demeter; H Heimpel
Journal:  Onkologie       Date:  1991-02

Review 2.  Cancer pain relief and palliative care. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1990

3.  Does a small minority of elderly account for a majority of health care expenditures? A sixteen-year perspective.

Authors:  N P Roos; E Shapiro; R Tate
Journal:  Milbank Q       Date:  1989       Impact factor: 4.911

Review 4.  Gerontology as oncology. Research on aging as the key to the understanding of cancer.

Authors:  R A Miller
Journal:  Cancer       Date:  1991-12-01       Impact factor: 6.860

5.  Weekly adriamycin versus VAC in advanced breast cancer. A randomized trial.

Authors:  S Gundersen; S Kvinnsland; O Klepp; S Kvaløy; E Lund; H Høst
Journal:  Eur J Cancer Clin Oncol       Date:  1986-12

6.  Acute lymphoblastic leukemia in patients over 59 years of age. Experience in a single center over a 10-year period.

Authors:  E Späth-Schwalbe; G Heil; H Heimpel
Journal:  Ann Hematol       Date:  1994-12       Impact factor: 3.673

7.  Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death.

Authors:  F J Cummings; R Gray; D C Tormey; T E Davis; H Volk; J Harris; G Falkson; J M Bennett
Journal:  J Clin Oncol       Date:  1993-01       Impact factor: 44.544

8.  The role of hospitals in caring for people in the last year of their lives.

Authors:  A Cartwright
Journal:  Age Ageing       Date:  1991-07       Impact factor: 10.668

Review 9.  Quality of life assessment in palliative care.

Authors:  I G Finlay; R Dunlop
Journal:  Ann Oncol       Date:  1994-01       Impact factor: 32.976

10.  Choice of cancer therapy varies with age of patient.

Authors:  J Samet; W C Hunt; C Key; C G Humble; J S Goodwin
Journal:  JAMA       Date:  1986-06-27       Impact factor: 56.272

View more
  1 in total

Review 1.  When drug treatment in the elderly is not cost effective. An ethical dilemma in an environment of healthcare rationing.

Authors:  R Chadwick; M Levitt
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.